Article Details
Retrieved on: 2024-06-17 17:28:50
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Wren Laboratories' efforts to integrate advanced diagnostic services into the biopharma sector through AI/ML liquid biopsy assays, supporting personalized medicine, biomarkers, and molecular diagnostics. Leadership enhancements and new prostate cancer diagnostics align with biopharma objectives.
Article found on: www.fox44news.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here